|
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. == History == Biogen was founded in 1978 in Geneva〔(【引用サイトリンク】title = Biotech's Comeback Kid )〕 by several prominent biologists, including Kenneth Murray of the University of Edinburgh, Phillip Allen Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard (who served as CEO during the start-up phase) and Charles Weissmann, University of Zurich (who contributed the first product interferon alpha). Gilbert and Sharp were subsequently honored with Nobel Prizes: Gilbert was recognized in 1980 with the Nobel Prize in Chemistry for his work in understanding DNA sequencing, while Sharp received the Nobel Prize in Physiology or Medicine in 1993 for his discovery of split genes. In 2003, Biogen merged with San Diego, California-based IDEC Pharmaceuticals (formed in 1986 by biotech pioneers Ivor Royston and Howard Birndorf) and adopted the name Biogen Idec. After the merge, Biogen Idec became the 3rd largest Biotechnology company in the world.〔(【引用サイトリンク】title = Idec to Merge With Biogen in $6.8 Billion Deal )〕 Following shifts in research core areas, the company has since shortened its name, reverting to simply Biogen.〔(【引用サイトリンク】title = Biogen Drops Idec From Name )〕 Biogen stock is a component of several stock indices such as the S&P 100, S&P 500, S&P 1500, and NASDAQ-100 and the company is listed on the NASDAQ stock exchange under the ticker symbol, BIIB.〔(【引用サイトリンク】title = Biogen Idec Inc. Stock Quote & Summary Data )〕 In January 2015 the company announced it will acquire Convergence Pharmaceuticals for up to $675 million, with the acquisition aiming to accelerate the development of Convergence's pipeline, in-particular CNV1014802 – a Phase II small molecule sodium channel blocking candidate.〔http://www.genengnews.com/gen-news-highlights/biogen-idec-snaps-up-convergence-for-up-to-675m/81250789/〕 In October 2015 the company announced it will lay off 11% of it's workforce, effective immediately.〔http://www.businessinsider.com/biogen-layoffs-cutting-11-of-workforce-2015-10〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Biogen」の詳細全文を読む スポンサード リンク
|